March 2026
1. TSUJI M, Kobayashi K, Kawakami K, Fukuda N, et al
   Real-world Analysis of Urinary Protein-to-Creatinine Ratio and Blood Pressure in Lenvatinib Therapy.
   Anticancer Res. 2026;46:1651-1659.
   

   >> Share

   
   November 2025
2. NAKAMURA Y, Nishimura-Yano Y, Nishimura M, Kokubo T, et al
   Spontaneous and Radiation-induced Mammary and Thyroid Tumorigenesis in LEW and (SDxCOP)F(1) Brca1 (L63X/+) Rats.
   Anticancer Res. 2025;45:4869-4880.
   

   >> Share

   
   October 2025
3. HONG J, Fan R, Gao Y, Moes G, et al
   Sellar Metastatic Follicular Thyroid Carcinoma With Novel Mutations Clinically Mimicking Pituitary Macroadenoma: Intraoperative Frozen Section Diagnosis Challenges.
   Anticancer Res. 2025;45:4637-4641.
   

   >> Share

   
   September 2025
4. ANZELLINI D, Loddo M, Del Bianco S
   Long-lasting Complete Remission Following Immunotherapy With Anti-PD1 Plus Anti-CTLA4 in a Polymetastatic Patient With NRAS (Q16R) Mutated Anaplastic Thyroid Carcinoma.
   Anticancer Res. 2025;45:3809-3816.
   

   >> Share

   
   April 2025
5. HAYASHI K, Ishida K, Kato M, Ohkubo S, et al
   Activation of DCTN1-RET Fusion Through Coiled-coil Domain as a Potential Target for RET Inhibitors.
   Anticancer Res. 2025;45:1407-1417.
   

   >> Share

   
   December 2024
6. BOWERS JC, Savaliya BP, Raikot SR, Ahmed SH, et al
   Survival Outcomes and Disparities in Surgery Refusal for Papillary Thyroid Cancer.
   Anticancer Res. 2024;44:5455-5461.
   

   >> Share

   
   October 2024
7. MIYAKE R, Takeyama H, Manome Y, Koyama M, et al
   Thyroid Cancer With Autocrine Sialyl-fibronectin Depletion Has a Poor Prognosis due to EMT Progression.
   Anticancer Res. 2024;44:4561-4568.
   

   >> Share

   
   
8. NA YM, Park SC, An SY, Ma HU, et al
   Analysis of Initial Outcomes of Gas-insufflation One-step Single-port Transaxillary (GOSTA) Robotic Thyroidectomy for Thyroid Cancer.
   Anticancer Res. 2024;44:4585-4592.
   

   >> Share

   
   July 2024
9. TODA S, Saito N, Kadoya M, Okubo Y, et al
   Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma.
   Anticancer Res. 2024;44:3141-3147.
   

   >> Share

   
   May 2024
10. JI N, Lee Y, Lee SH, Kim HS, et al
    Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
    Anticancer Res. 2024;44:2159-2170.
    

    >> Share

    
    January 2024
11. YOSHIMURA N, Fujiwara M, Igeta M, Suzuki H, et al
    Risk Factors Causing Hypothyroidism in Patients With Head and Neck Cancer After Radiotherapy Using SIB-VMAT.
    Anticancer Res. 2024;44:323-329.
    

    >> Share

    
    November 2023
12. KOWKABANY G, Jimenez PB, Sharan S, Bansal S, et al
    Inequities in Time to Treat Thyroid Cancer.
    Anticancer Res. 2023;43:5025-5030.
    

    >> Share

    
    October 2023
13. ZHOU J, Liu J, Zhang KE, Lv J, et al
    High-throughput Sequencing Analysis of Differentially Expressed microRNAs Associated With SREBP1 in Differentiated Thyroid Carcinoma.
    Anticancer Res. 2023;43:4435-4446.
    

    >> Share

    
    April 2023
14. LANDSTROM F, Sandberg J, Reizenstein J
    Life-threatening Airway Complication After Radioactive Iodine Treatment: A Case Report and Review of the Literature.
    Anticancer Res. 2023;43:1853-1855.
    

    >> Share

    
    March 2023
15. NAKAYAMA H, Saito N, Kasajima R, Suganuma N, et al
    Validation of EZH2 Inhibitor Efficiency in Anaplastic Thyroid Carcinoma Cell Lines.
    Anticancer Res. 2023;43:1073-1077.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share